Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariano Monzó

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
International Journal of Molecular Sciences|May 31, 2017
Non-Coding RNAs in Hodgkin LymphomaAnna Cordeiro, Mariano Monzó, Alfons Navarro
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 23, 2008
Pharmacogenomics: a tool for improving cancer chemotherapyMariano Monzó, Alfons Navarro, Gerardo Ferrer, et al.
Anatomical Record (Hoboken, N.J. : 2007)|February 2, 2011
Ultrastructural and immunohistochemical analysis of intestinal myofibroblasts during the early organogenesis of the human small intestineRosa Artells, Alfons Navarro, Tània Diaz, et al.
Acta Oto-Laryngologica|October 30, 2009
Weekly paclitaxel for platin-resistant stage IV head and neck cancer patientsJuan José Grau, Miguel Caballero, Eugenia Verger, et al.
Plos One|November 3, 2018
miR-21, miR-99b and miR-375 combination as predictive response signature for preoperative chemoradiotherapy in rectal cancerMarc Campayo, Alfons Navarro, Jose Carlos Benítez, et al.
Leukemia & Lymphoma|January 15, 2015
Epigenetic regulation of microRNA expression in Hodgkin lymphomaAlfons Navarro, Tania Díaz, Anna Cordeiro, et al.
Acta Oto-Laryngologica|March 17, 2007
Expression of cyclooxygenase-2 mRNA in peripheral blood of head and neck cancer patients and in healthy controls. A pilot studyJuan J Grau, Mariano Monzó, Miguel Caballero, et al.
Seminars in Oncology|March 15, 2002
Determinants of response and resistance to cytotoxicsRafael Rosell, Mariano Monzó, Vicente Alberola, et al.
Plos One|May 25, 2013
MiR-SNPs as markers of toxicity and clinical outcome in Hodgkin lymphoma patientsAlfons Navarro, Carmen Muñoz, Anna Gaya, et al.
Leukemia Research|March 26, 2011
Impact on response and survival of DNA repair single nucleotide polymorphisms in relapsed or refractory multiple myeloma patients treated with thalidomideMaría Teresa Cibeira, Carlos Fernández de Larrea, Alfons Navarro, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
International Journal of Molecular Sciences|May 31, 2017
Non-Coding RNAs in Hodgkin LymphomaAnna Cordeiro, Mariano Monzó, Alfons Navarro
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 23, 2008
Pharmacogenomics: a tool for improving cancer chemotherapyMariano Monzó, Alfons Navarro, Gerardo Ferrer, et al.
Anatomical Record (Hoboken, N.J. : 2007)|February 2, 2011
Ultrastructural and immunohistochemical analysis of intestinal myofibroblasts during the early organogenesis of the human small intestineRosa Artells, Alfons Navarro, Tània Diaz, et al.
Acta Oto-Laryngologica|October 30, 2009
Weekly paclitaxel for platin-resistant stage IV head and neck cancer patientsJuan José Grau, Miguel Caballero, Eugenia Verger, et al.
Plos One|November 3, 2018
miR-21, miR-99b and miR-375 combination as predictive response signature for preoperative chemoradiotherapy in rectal cancerMarc Campayo, Alfons Navarro, Jose Carlos Benítez, et al.
Leukemia & Lymphoma|January 15, 2015
Epigenetic regulation of microRNA expression in Hodgkin lymphomaAlfons Navarro, Tania Díaz, Anna Cordeiro, et al.
Acta Oto-Laryngologica|March 17, 2007
Expression of cyclooxygenase-2 mRNA in peripheral blood of head and neck cancer patients and in healthy controls. A pilot studyJuan J Grau, Mariano Monzó, Miguel Caballero, et al.
Seminars in Oncology|March 15, 2002
Determinants of response and resistance to cytotoxicsRafael Rosell, Mariano Monzó, Vicente Alberola, et al.
Plos One|May 25, 2013
MiR-SNPs as markers of toxicity and clinical outcome in Hodgkin lymphoma patientsAlfons Navarro, Carmen Muñoz, Anna Gaya, et al.
Leukemia Research|March 26, 2011
Impact on response and survival of DNA repair single nucleotide polymorphisms in relapsed or refractory multiple myeloma patients treated with thalidomideMaría Teresa Cibeira, Carlos Fernández de Larrea, Alfons Navarro, et al.
Pageof 3